OTC : CMXHF

CSL Limited

$81.96 USD

$0 (0.0%)

Volume
200
Average Volume
2.64K
Market Capitalization
$39.25B
P/E Ratio
26.76
Dividend Yield
3.73%
Price Target
Year High
$184.09
Year Low
$63.84
Day High
—
Day Low
—
Payout Ratio
$1.03
Current Ratio
$2.57
Company Overview

OTC

Gordon Naylor DipCompSc

Biotechnology

Healthcare

CMXHF

32698

AU

USD

https://www.csl.com

61 3 9389 1911

N/A

0001274152

Liquidity Metrics

0.67

2.57

1.15

0.25

1.03

Sales & Valuation

$15.43B

2.43

2.07

12.01

6.58

Profitability

$6.17

$3B

9.17%

10.29%

7.56%

3.80%

P/E Metrics

26.76

-0.50

-0.50

Analyst Price Target & Rating

Neutral

3/5

0 Analysts

%

Financial Health Scores

3.79

6/9

$7.25B

$37.92B

$17.45B

$8.12B

Key Metrics (TTM)

$50.24B

3.20

9.76

2.57

7.56%

10.37%

3.67%

8.20%

$50.86

250 days

Company Executives
Name Title
Mark Dehring Head of Investor Relations
William Mezzanotte Chief Medical Officer, Executive Vice President and Head of Research & Development
Mark Hill Chief Digital Information Officer & Executive Vice President
Gordon Naylor DipCompSc CEO, MD & Director
Stephen Marlow Executive VP & GM of CSL Plasma
Gregory Boss Executive VP of Legal & Group General Counsel
Amy Van Buren Chief People Officer
Deirdre BeVard Senior Vice President of Research & Development Strategic Operations
Mary Oates Executive VP & COO
Ken Lim Chief Financial Officer
Poll Results

No votes yet today — be the first to share your view!

About CSL Limited (OTC:CMXHF) Stock

CSL Limited is a global biopharmaceutical enterprise engaged in the discovery, development, production, marketing, and distribution of a wide array of medicinal and related products. Its operations span key markets including Australia, the United States, Germany, the United Kingdom, Switzerland, and China. The company's activities are organized into two primary divisions: CSL Behring and Seqirus. CSL Behring specializes in plasma-derived therapies, delivering essential plasma products and recombinant treatments designed to manage a range of serious conditions such as immunodeficiencies, various bleeding disorders, hereditary angioedema, Alpha-1 antitrypsin deficiency, and certain neurological ailments. Beyond its therapeutic offerings, this division actively pursues research in both plasma ... and non-plasma-based treatments, and also generates revenue through licensing and royalties from its intellectual property commercialization. Meanwhile, Seqirus focuses on the manufacturing and distribution of non-plasma biotherapeutics, alongside the development of innovative influenza vaccines and related products. Established in 1916, CSL Limited maintains its corporate headquarters in Parkville, Australia.

CSL Plunges 22% After Cutting Outlook And Flagging $5 Billion Impairments

2026-05-11 07:38:00

CSL Ltd. (CMXHF) suffered its sharpest share-price drop on record after the Australian biotechnology company cut its full-year outlook, warned that its turnarou

Frequently Asked Questions

What is the current CSL Limited (CMXHF) stock price?

CSL Limited(OTC:CMXHF) stock price is $81.96 in the last trading session. During the trading session, CMXHF stock reached the peak price of $184.09 while $63.84 was the lowest point it dropped to. The percentage change in CMXHF stock occurred in the recent session was 0.0% while the dollar amount for the price change in CMXHF stock was $0.

CMXHF's industry and sector of operation?

The OTC listed CMXHF is part of Biotechnology industry that operates in the broader Healthcare sector.

Who are the executives of CMXHF?

Mark Dehring | Head of Investor Relations
William Mezzanotte | Chief Medical Officer, Executive Vice President and Head of Research & Development
Mark Hill | Chief Digital Information Officer & Executive Vice President
Gordon Naylor DipCompSc | CEO, MD & Director
Stephen Marlow | Executive VP & GM of CSL Plasma

How many employees does CMXHF have?

Number of CMXHF employees currently stands at 32698. CMXHF operates from 655 Elizabeth Street, Melbourne, VIC 3052, AU.

Link for CMXHF official website?

Official Website of CMXHF is: https://www.csl.com

How do I contact CMXHF?

CMXHF could be contacted at phone #61 3 9389 1911 and can also be accessed through its website. CMXHF operates from 655 Elizabeth Street, Melbourne, VIC 3052, AU.

How many shares of CMXHF are traded daily?

The average number of CMXHF shares traded daily for last 3 months was 2.64K.

What is the market cap of CMXHF currently?

The market value of CMXHF currently stands at $39.25B with its latest stock price at $81.96